Contracts › 75F40126F19001
75F40126F19001: Ffp Task Order for Proton Pump Inhibitor Pk Study for the Fda's Center for Drug Evaluation and Research (CDER), Office of Generic Drugs (OGD).
Awarded to Tranquil Clinical and Research Consulting Services Llc by Food and Drug Administration (FDA).
$1.2Mobligated
$2.1Mpotential value
29 March 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40126F19001 |
|---|---|
| Vehicle | 75F40125D00003 |
| Awardee | Tranquil Clinical and Research Consulting Services Llc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 Research and Development in Biotechnology (Except Nanobiotechnology) |
| PSC | AJ12 General Science and Technology R&D Services; General Science and Technology; Applied Research |
| Place of performance | MD |
| Period of performance | 30 September 2026 to 29 March 2028 |
| Potential end | 29 September 2029 |
| Estimated recompete solicitation | ~Q4 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 06 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541714 contracts · All expiring contracts · USASpending record